Results 91 to 100 of about 3,021,164 (249)

Carbohydrate antigen 125 in heart failure: congestive kidneys or beyond? [PDF]

Eur Heart J Acute Cardiovasc Care, 2021
Higgins A, Tang WHW.
europepmc   +1 more source

Pharmacological treatment of chronic congestive heart failure

, 2017
Congestive heart failure is a common clinical disorder that results in pulmonary vascular congestion and reduced cardiac output. Common symptoms include shortness of breath and fatigue and should be considered as a differential diagnosis for any adult ...
Kufuor, Nana Kofi Darko
core  

More Improved Postoperative Range‐of‐Motion Retention After Arthroscopic Lysis of Adhesions After Total Knee Arthroplasty Is Associated With Arthroscopic Fellowship‐Trained Compared With Nonfellowship‐Trained Surgeons

Arthroscopy, Sports Medicine, and Rehabilitation, EarlyView.
Purpose To describe whether subspecialty training, specifically arthroscopic fellowship training, influences intraoperative range‐of‐motion (ROM) gains, postoperative ROM retention, and lysis of adhesions (LOA) complication rates. Methods Between August 1989 and May 2025, all patients who underwent arthroscopic LOA for stiffness after primary total ...
George Bcharah, Alexandra Cancio‐Bello, Calvin Nguyen, Eugenia Lin, Mario Hevesi, Cedric J. Ortiguera, Anikar Chhabra, Joshua Bingham   +7 more
wiley   +1 more source

Cytokine Pathways Driving Diverse Tissue Pathologies in Rheumatoid Arthritis

Arthritis &Rheumatology, EarlyView.
Rheumatoid arthritis (RA) is a complex systemic disorder characterized primarily by articular inflammation and destruction with associated functional loss and reduced quality of life. RA is also associated with extra‐articular disease, such as that of the lung, with potentially devastating clinical consequences. The critical importance of comorbidities,
Aurelie Najm, Lyn D. Ferguson, Iain B. McInnes   +2 more
wiley   +1 more source

Modeling payback from research into the efficacy of left-ventricular assist devices as destination therapy [PDF]

, 2007
Objectives: Ongoing developments in design have improved the outlook for left-ventricular assist device (LVAD) implantation as a therapy in end-stage heart failure.
Freeman, G, Freeman, G., Poole-Wilson, P, Lilford, Richard J, Girling, A., Freeman, Guy, Lilford, RJ, Scott, D., Gordon, JP, Girling, Alan, Lilford, Richard, Gordon, Jason P, Poole-Wilson, Philip, Girling, AJ, Scott, David A, Girling, Alan J., Gordon, Jason, Scott, David A., Scott, DA, Gordon, Jason P., Lilford, R., Girling, Alan J, Poole-Wilson, P., Gordon, J., Scott, D   +24 more
core   +1 more source

Efficacy and Safety of Nanoencapsulated Sirolimus Plus Pegadricase: Results From the Randomized, Placebo‐Controlled Phase 3 Trials

Arthritis &Rheumatology, EarlyView.
Objective DISSOLVE I and II examined the efficacy and safety of nanoencapsulated sirolimus (NAS) plus pegadricase (NASP) in patients with uncontrolled gout (UG). Methods In these double‐blind, placebo‐controlled Phase 3 trials of NASP, patients were randomized 1:1:1 to infusions of high‐dose (HD) or low‐dose (LD) NAS plus pegadricase (HD NASP, LD NASP,
Herbert S. B. Baraf, Puja P. Khanna, Milan Petronijevic, Mamuka Lortkipanidze, Anand Patel, Kwabena Ayesu, Michael H. Pillinger, Atul Singhal, Joanna Sobierska, Jacquie Christie, Peter Traber, Rehan Azeem, Wesley DeHaan, Hugues Santin‐Janin, Bhavisha Desai, Alan Kivitz   +15 more
wiley   +1 more source

Brachial pulse pressure in acute heart failure. Results of the Heart Failure Registry [PDF]

, 2019
[Abstract] Aims To investigate the still uncertain independent prognostic impact of pulse pressure (PP) in acute heart failure (HF), in particular across the left ventricular ejection fraction (EF) phenotypes, and the potential contribution of PP in ...
Macarie, Cezar,, Laroche, Cécile, Bonapace, Stefano,, Maggioni, Aldo P.,, Crespo-Leiro, Maria G., Ulf Dahlström, Maggioni, Aldo P, Andrea Rossi, Piepoli, Massimo F.,, Andrew J.S. Coats, Pier Luigi Temporelli, Maria G. Crespo‐Leiro, Malek, Filip, Tavazzi, Luigi,, Temporelli, Pier Luigi, Crespo-Leiro, María Generosa, Rossi, Andrea,, Rossi, Andrea, Stefano Bonapace, Cécile Laroche, Crespo-Leiro, Maria G.,, Bonapace, Stefano, Malek, Filip,, Dahlström, Ulf, Temporelli, Pier Luigi,, Coats, Andrew J S, Massimo F. Piepoli, Piepoli, Massimo F, Macarie, Cezar, Coats, Andrew J. S.,, Coats, Andrew J. S., Laroche, Cecile,, Filip Malek, Crespo Leiro, Marisa, Cezar Macarie, Luigi Tavazzi, Maggioni, Aldo P., Dahlström, Ulf,, Tavazzi, Luigi, Aldo P. Maggioni, Piepoli, Massimo F.   +40 more
core   +1 more source

Pharmacokinetics, Effectiveness and Safety of Certolizumab Pegol in Children and Adolescents With Active Juvenile Idiopathic Arthritis: 9+‐Year Results From a Multicenter, Open‐Label Study

Arthritis &Rheumatology, EarlyView.
Objective The purpose of this study was to assess the pharmacokinetics, effectiveness, safety, and immunogenicity of certolizumab pegol (CZP) in polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods Pediatric Arthritis Study of Certolizumab Pegol (NCT01550003), a multicenter, open‐label study, enrolled patients aged 2 to 17 years with ...
Hermine I. Brunner, Lyudmila Grebenkina, Irina Nikishina, Ekaterina Alexeeva, Vyacheslav Chasnyk, Carlos Abud‐Mendoza, Nadina Rubio‐Pérez, Heinrike Schmeling, María del Rocio Maldonado‐Velázquez, Diane Brown, Andrew Zeft, Esi Morgan, C. Egla Rabinovich, Daniel Kingsbury, Hulya Bukulmez, Beth Gottlieb, Thomas Griffin, Lisa Imundo, Stacey Tarvin, Earl Silverman, Laura Shaughnessy, Saori Shimizu, Paulette Williams, Rocío Lledó‐García, Gauri Utturkar, Baran Ufuktepe, Alberto Martini, Daniel J. Lovell, Nicolino Ruperto, the Paediatric Rheumatology International Trials Organisation (PRINTO); the Pediatric Rheumatology Collaborative Study Group (PRCSG), Hermine I. Brunner, Lyudmila Grebenkina, Irina Nikishina, Ekaterina Alexeeva, Vyacheslav Chasnyk, Carlos Abud‐Mendoza, Nadina Rubio‐Pérez, Heinrike Schmeling, María del Rocio Maldonado‐Velázquez, Diane Brown, Andrew Zeft, Esi Morgan, C. Egla Rabinovich, Daniel Kingsbury, Hulya Bukulmez, Beth Gottlieb, Thomas Griffin, Lisa Imundo, Stacey Tarvin, Earl Silverman, Alberto Martini, Daniel L. Lovell, Nicolino Ruperto   +52 more
wiley   +1 more source

Peritoneal dialysis in congestive heart failure

SA Heart Journal, 2017
Heart failure is a major and growing health problem. There have been major advances in the understanding of pathophysiology of heart failure as a chronic progressive disorder, which has led to newer therapies.
Abirami Krishnan, D.G. Oreopoulos
doaj   +1 more source

Congestive heart failure [PDF]

Congestive heart failure (CHF) is a serious medical condition in which the heart cannot pump enough blood to meet the body's needs. CHF is often caused by hypertension, diabetes, or coronary heart disease.

core